Martin Lechmann und Development - Info zur Person

(1 - 6 von 8

)

Immunogenicity

myeventflo.com

•Martin Lechmann,Development DMPK Project Leader, Roche Key Speakers include: •Robert Dodge, Associate Director, BMS •Thomas Lee, Scientific Investigator, ...

SMi is launching its inaugural Immunogenicity Conference

www.prweb.com

Matthew Baker, Chief Scientific Officer, Antitope; Martin Lechmann,Development DMPK Project Leader, Roche. Key Speakers include:.

Особенности эпидемиологии и оценка путей передачи возбудителей...

medical-diss.com

Martin Lechmann Ph. D. Vaccine Development' for Hepatitis С / Ph. D.Martin Lechmann, M. D. T. Jake Liang // Sem. Liver Dis Vol. 20, №2.-P

| Nature Careers

www.nature.com

Conference Chairs: •Matthew Baker, Chief Scientific Officer, Antitope •Martin Lechmann,Development DMPK Project Leader, Roche. Key Speakers include:.

conference chairs: matthew baker, Chief Scientific Officer, Antitope...

businessdocbox.com

conference chairs: matthew baker, Chief Scientific Officer, Antitope martin lechmann, Development DMPK Project Leader, Roche Key Speakers include: ...